1 - L1_OMALIZUMAB (DOE)
Tender information
TED EUVitoria-Gasteiz, Spain
- Type
- 38
- Ref. number
- 177090-2026
- Estimated value
- 4,686,183 EUR
- CPV
- 33600000
Suministro de Omalizumab (DOE), Nilotinib (DOE), Eltrombopag (DOE), Dabrafenib (DOE), Secukinumab (DOE), Pazopanib (DOE), Trametinib (DOE), Everolimus (DOE) y Midostaurina (DOE)